홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-(2-Methoxyethyl)piperazine → 2-{6-[4-(2-Methoxyethyl)piperazin-1-yl]pyrimidin-4-yl}-4-pyridin-3-yl-1,2-dihydro-3H-pyrazol-3-one dihydrochloride

HRID 37903
인쇄

반응식

HRID 37903 반응식
[Cl:1][C:2]1[N:7]=[CH:6][N:5]=[C:4]([N:8]2[C:12](=[O:13])[C:11]([C:14]3[CH:15]=[N:16][CH:17]=[CH:18][CH:19]=3)=[CH:10][NH:9]2)[CH:3]=1.[CH3:20][O:21][CH2:22][CH2:23][N:24]1[CH2:29][CH2:28][NH:27][CH2:26][CH2:25]1>C1COCC1>[ClH:1].[ClH:1].[CH3:20][O:21][CH2:22][CH2:23][N:24]1[CH2:29][CH2:28][N:27]([C:2]2[N:7]=[CH:6][N:5]=[C:4]([N:8]3[C:12](=[O:13])[C:11]([C:14]4[CH:15]=[N:16][CH:17]=[CH:18][CH:19]=4)=[CH:10][NH:9]3)[CH:3]=2)[CH2:26][CH2:25]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 27346381-(2-Methoxyethyl)piperazineHCID 866723282-(6-Chloropyrimidin-4-yl)-4-pyridin-3-yl-1,2-dihydro-3H-pyrazol-3-one

생성물 1

HCID 688050852-{6-[4-(2-Methoxyethyl)piperazin-1-yl]pyrimidin-4-yl}-4-pyridin-3-yl-1,2-dihydro-3H-pyrazol-3-one dihydrochloride

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

실험 절차

100 mg (0.4 mmol) of the compound from Example 23 and 113 mg (0.7 mmol) of N-(methoxy-ethyl)piperazine are initially charged in 3 ml of THF. The reaction mixture is reacted in a single-mode microwave oven (Emrys Optimizer) at 120° C. for 20 min. The cooled reaction solution is then concentrated on a rotary evaporator, and the residue is chromatographed by preparative HPLC (RP18 column; mobile phase: acetonitrile/water gradient with addition of 0.1% formic acid). 1 ml of a 4 N solution of hydrogen chloride in dioxane is added to the resulting formate salt of the target compound, and the mixture is stirred at RT for 30 min. The suspension is then concentrated under reduced pressure, and the residue is dried.

후처리

  1. customThe reaction mixture is reacted in a single-mode microwave oven (Emrys Optimizer) at 120° C. for 20 min
  2. customThe cooled reaction solution
  3. concentrationis then concentrated on a rotary evaporator
  4. customthe residue is chromatographed by preparative HPLC (RP18 column; mobile phase: acetonitrile/water gradient with addition of 0.1% formic acid)
  5. addition1 ml of a 4 N solution of hydrogen chloride in dioxane is added to the resulting formate salt of the target compound
  6. concentrationThe suspension is then concentrated under reduced pressure
  7. customthe residue is dried

출처 및 근거

ORD 기록
ord-05c5bf2623c84748a380e226ad03f216
출처 데이터셋
uspto-grants-2013_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08524699B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트